Jun 03, 2020
New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis
May 29, 2020
PathAI Demonstrates the Potential of AI-based Characterization of the Tumor Microenvironment at ASCO
May 29, 2020
Medicenna Updates Efficacy Results from Phase 2b Recurrent GBM Trial at ASCO 2020
Apr 23, 2020
Leap Therapeutics to Present Updated Data for DKN-01 Monotherapy and Paclitaxel Combination In Gynecologic Cancers
Apr 07, 2020
Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma Study
Nov 25, 2019
Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference
Oct 15, 2019
Health Canada Approves Ipsen's CABOMETYX(TM) (cabozantinib) for the First-Line Treatment of Adults with Advanced Renal Cell Carcinoma
Jun 02, 2019
Daiichi Sankyo Presents Preliminary Phase 1 Data for TROP2 Targeting ADC DS-1062 in Patients with Non-Small Cell Lung Cancer at 2019 ASCO Annual Meeting
May 23, 2019
Cstone partner Agios Announces the Phase 3 ClarIDHy Trial of TIBSOVO (ivosidenib) Achieved its Primary Endpoint
Mar 01, 2019
Many Look Beyond Chemotherapy to Combat the Swelling Incidence of Cancer
Feb 07, 2019
Paramount Developments Crucial for Advancing Clinical Trials Targeting Cancer Treatments
Oct 25, 2018
Syndax to Host Conference Call to Provide Update on the Phase 3 Breast Cancer Trial (E2112) and to Announce its Registration Trial of Entinostat with Keytruda in PD-(L)1 Refractory Non-Small Cell Lung Cancer
Sep 19, 2018
Health Canada Approves Ipsen's CABOMETYX(TM) (cabozantinib) Giving Physicians and Patients a Novel Second-Line Option in the Fight Against Advanced Renal Cell Carcinoma
Jul 18, 2018
FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency
Jun 21, 2018
Taiho Oncology and Servier Present Data on LONSURF® (trifluridine and tipiracil) at ESMO 20th World Congress on Gastrointestinal Cancer 2018
Apr 10, 2018
Hematogenix Laboratory Services Launches Minimal Residual Disease (MRD) Evaluation for Chronic Lymphocytic Leukemia (CLL) Using the Standardized ERIC Method
Feb 21, 2018
Bayer Announces Publication of Larotrectinib Data in The New England Journal of Medicine
Feb 20, 2018
PharmaMar's Lurbinectedin ATLANTIS trial design and data in small-cell lung cancer will be an oral presentation at the IASCLC´s annual meeting
Feb 16, 2018
FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing
Sep 24, 2017
Adding radiation to chemotherapy may dramatically improve survival for advanced-stage NSCLC patients